Literature DB >> 23903540

Stability of cervical specimens in SurePath medium for human papillomavirus testing with the Roche cobas 4800 assay.

Laura Gilbert1, Elizabeth Oates, Samuel Ratnam.   

Abstract

The stability of cervical specimens in SurePath preservative fluid for human papillomavirus (HPV) testing with Roche cobas 4800 was determined using a panel of 308 pooled specimens from a colposcopy referral population. The SurePath specimens appeared to be stable for up to 10 weeks at ambient temperature for HPV testing with cobas 4800.

Entities:  

Mesh：

Year:  2013        PMID： 23903540      PMCID： PMC3811638          DOI： 10.1128/JCM.01391-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.

Authors:  Julia C Gage; Mark Sadorra; Brandon J Lamere; Randi Kail; Carrie Aldrich; Walter Kinney; Barbara Fetterman; Thomas Lorey; Mark Schiffman; Philip E Castle
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

Authors:  D A M Heideman; A T Hesselink; J Berkhof; F van Kemenade; W J G Melchers; N Fransen Daalmeijer; M Verkuijten; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

3.  Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results.

Authors:  Thomas C Wright; Mark H Stoler; Abha Sharma; Guili Zhang; Catherine Behrens; Teresa L Wright
Journal:  Am J Clin Pathol       Date:  2011-10       Impact factor: 2.493

4.  Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.

Authors:  Samuel Ratnam; Francois Coutlee; Dan Fontaine; James Bentley; Nicholas Escott; Prafull Ghatage; Veeresh Gadag; Glen Holloway; Elias Bartellas; Nick Kum; Christopher Giede; Adrian Lear
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

5.  Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology.

Authors:  Andreas Clad; Miriam Reuschenbach; Johanna Weinschenk; Ruth Grote; Janina Rahmsdorf; Nikolaus Freudenberg
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

6.  Formaldehyde substitute fixatives: effects on nucleic acid preservation.

Authors:  Cathy B Moelans; Daphne Oostenrijk; Michiel J Moons; Paul J van Diest
Journal:  J Clin Pathol       Date:  2011-06-29       Impact factor: 3.411

7.  Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer.

Authors:  Samuel Ratnam; Francois Coutlee; Dan Fontaine; James Bentley; Nicholas Escott; Prafull Ghatage; Veeresh Gadag; Glen Holloway; Elias Bartellas; Nick Kum; Christopher Giede; Adrian Lear
Journal:  J Clin Microbiol       Date:  2010-12-08       Impact factor: 5.948

8.  Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study.

Authors:  J Thomas Cox; Phillip E Castle; Catherine M Behrens; Abha Sharma; Thomas C Wright; Jack Cuzick
Journal:  Am J Obstet Gynecol       Date:  2012-11-19       Impact factor: 8.661

9.  Prevalence and Distribution of High-Risk Genotypes of HPV in Women with Severe Cervical Lesions in Madrid, Spain: Importance of Detecting Genotype 16 and Other High-Risk Genotypes.

Authors:  Maria Luisa Mateos Lindemann; Juan Manuel Sánchez Calvo; Jesús Chacón de Antonio; Itziar Sanz; Esperanza Diaz; Maria Dolores Rubio; Maria Luisa de la Morena
Journal:  Adv Prev Med       Date:  2010-09-27

10.  Comparison of the Cobas 4800 HPV test and the Seeplex HPV4A ACE with the hybrid capture 2 test.

Authors:  Eun Young Ki; Hee Eun Kim; Yeong-Jin Choi; Jong-Sup Park; Chang Seok Kang; Ahwon Lee
Journal:  Int J Med Sci       Date:  2012-12-30       Impact factor: 3.738
View more
  7 in total

1.  Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests.

Authors:  Keith D Tardif; Michael T Pyne; Elisabeth Malmberg; Tatum C Lunt; Robert Schlaberg
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

2.  Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules.

Authors:  Hyemi Kwon; Won Gu Kim; Markus Eszlinger; Ralf Paschke; Dong Eun Song; Mijin Kim; Suyeon Park; Min Ji Jeon; Tae Yong Kim; Young Kee Shong; Won Bae Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2016-11-04

3.  Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test.

Authors:  Chun-Qing Lin; Xi Zeng; Jian-Feng Cui; Guang-Dong Liao; Ze-Ni Wu; Qian-Qian Gao; Xun Zhang; Xiu-Zhang Yu; Wen Chen; Ming-Rong Xi; You-Lin Qiao
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

4.  HPV genotyping and p16/Ki-67 test significantly improve detection rate of high-grade cervical squamous intraepithelial lesion.

Authors:  Piotr Lewitowicz; Anna Nasierowska-Guttmejer; Wojciech Rokita; Olga Adamczyk-Gruszka; Stanisław Gluszek; Magdalena Chrapek; Małgorzata Kolos; Agnieszka Wrona-Cyranowska; Marcin Misiek
Journal:  Arch Med Sci       Date:  2019-01-11       Impact factor: 3.318

5.  A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics.

Authors:  Kristin Lm Boylan; Somaieh Afiuni-Zadeh; Melissa A Geller; Kayla Hickey; Timothy J Griffin; Stefan E Pambuccian; Amy Pn Skubitz
Journal:  Clin Proteomics       Date:  2014-07-14       Impact factor: 3.988

6.  An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media.

Authors:  Hongxue Luo; Hui Du; Kathryn Maurer; Jerome L Belinson; Guixiang Wang; Zhihong Liu; Lijie Zhang; Yanqiu Zhou; Chun Wang; Jinlong Tang; Xinfeng Qu; Ruifang Wu
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

7.  Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens.

Authors:  Max Chernesky; Dan Jang; Nick Escott; Jodi Gilchrist; Jenny Li; Laurie Elit; Alice Lytwyn; Marek Smieja; Sam Ratnam; Manuel Arias; Damon Getman; Barbara Weinbaum; Brett Kirkconnell; Janel Dockter
Journal:  Papillomavirus Res       Date:  2017-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.